Trichlorethanol

Trichlorethanol

SCHEMBL2432677

CCCCCCCC(=O)OCC.OCC(Cl)(Cl)Cl

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.58
PAM P19021 2/20 0.53
LMNA P02545 2/20 0.51
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
MAPT P10636 2/20 0.50
TSHR P16473 1/20 0.50
PRKCA P17252 3/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCD Q05655 1/20 0.49
DNM1 Q05193 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.48
GAA P10253 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3316257 0.87 DGKA (0.60) DGKAPAMLMNAKDM4EDUSP3
Alcohol SCHEMBL258885 0.87 DGKA (0.69) DGKAPAMLMNAKDM4EDUSP3
Alcohol SCHEMBL2306576 0.87 DGKA (0.69) DGKAPAMLMNAKDM4EDUSP3
Alcohol SCHEMBL27646145 0.87 DGKA (0.69) DGKAPAMLMNAKDM4EDUSP3
Alcohol SCHEMBL7360903 0.87 DGKA (0.69) DGKAPAMLMNAKDM4EDUSP3
Hexane SCHEMBL2349171 0.87 DGKA (0.75) DGKAPAMLMNAKDM4EDUSP3
SCHEMBL8375548 0.87 DGKA (0.75) DGKAPAMLMNAKDM4EDUSP3
SCHEMBL6443707 0.87 DGKA (0.75) DGKAPAMLMNAKDM4EDUSP3
SCHEMBL900615 0.87 DGKA (0.75) DGKAPAMLMNAKDM4EDUSP3
Hexane SCHEMBL3151787 0.87 DGKA (0.75) DGKAPAMLMNAKDM4EDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346982-B1 VLA-4 INHIBITORS DAIICHI SEIYAKU CO (JP) 2011-09-14 EP disclosed
CN-100471838-C VLA-4 inhibitors DAIICHI SEIYAKU CO (JP) 2009-03-25 CN disclosed
CN-100396680-C Vla-4 inhibitors DAICHI PHARMACEUTICAL CO LTD (JP) 2008-06-25 CN disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
CN-1699363-A Vla-4 inhibitors DAICHI PHARMACEUTICAL CO LTD (JP) 2005-11-23 CN disclosed
US-20040110945-A1 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
CN-1483024-A Vla-4 inhibitors ��һ��������ҩ��ʽ���� 2004-03-17 CN disclosed
EP-1346982-A1 VLA-4 INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110945-A1 Vla-4 inhibitors VCAM1, ITGA1, ITGB4 DGKA 3330/4885PAM 2723/4885LMNA 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.